SELLAS Life Sciences Group, Inc. (SLS) Earnings History
Net Loss20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
SELLAS Life Sciences Group, Inc. (SLS) Earnings Overview
As of June 22, 2026, SELLAS Life Sciences Group, Inc. (SLS) reported trailing twelve-month net income of -$29M, reflecting +50.0% year-over-year growth. The company earned $-0.17 per diluted share over the past four quarters.
Looking at the long-term picture, SLS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2006.
SELLAS Life Sciences Group, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), ADMA ($165M net income, 28.8% margin), NKTR (-$158M net income, -297.1% margin), SLS has comparable earnings metrics. Compare SLS vs IMVT →
SLS Earnings vs Peers
Earnings metrics vs comparable public companies
SLS Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$27M | +13.0% | -$28M | $-0.25 | - | - |
| 2024 | -$31M | +17.3% | -$32M | $-0.50 | - | - |
| 2023 | -$37M | +9.6% | -$38M | $-1.34 | - | - |
| 2022 | -$41M | -99.5% | -$42M | $-2.13 | -4130.1% | -4195.0% |
| 2021 | -$21M | -23.5% | -$25M | $-1.34 | -272.4% | -332.8% |
| 2020 | -$17M | +13.1% | -$17M | $-2.11 | -881.9% | -893.8% |
| 2019 | -$19M | +30.3% | -$20M | $-10.92 | - | - |
| 2018 | -$28M | -16.5% | -$32M | $-157.72 | - | - |
| 2017 | -$24M | -0.9% | -$16M | $-521.91 | - | - |
| 2016 | -$24M | +63.1% | -$16M | $-933.13 | - | - |
| 2015 | -$64M | -74.6% | -$34M | $-411.55 | - | - |
| 2014 | -$37M | +52.3% | -$37M | $-1022.20 | -392.8% | -392.8% |
| 2013 | -$77M | -119.3% | -$34M | $-25500.26 | -3083.2% | -1360.7% |
| 2012 | -$35M | -204.5% | -$21M | $-1866.21 | -1715.8% | -1040.2% |
| 2011 | -$11M | +4.2% | -$21M | $-1053.77 | - | - |
| 2010 | -$12M | +34.8% | -$17M | $-2177.38 | - | - |
| 2009 | -$18M | -27.9% | -$18M | $-3783.33 | - | - |
| 2008 | -$14M | -30.8% | -$15M | $-3486.90 | - | - |
| 2007 | -$11M | -357.0% | -$11M | $-2893.63 | - | - |
| 2006 | -$2M | - | -$2M | $-636.24 | - | - |
Download Data
Export SLS earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SLS — Frequently Asked Questions
Quick answers to the most common questions about buying SLS stock.
What is SLS earnings per share (EPS)?
SLS trailing twelve-month (TTM) diluted EPS is $-0.17, reflecting +50.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.
What is SELLAS Life Sciences Group, Inc.'s net income?
SELLAS Life Sciences Group, Inc. (SLS) trailing twelve-month net income is $-29M as of 2025. Earnings grew +50.0% year-over-year.
Is SLS profitable?
SLS is not currently profitable on a TTM basis, reporting a net loss of $-29M. Net margin is N/A. Investors should monitor for a return to profitability.
What is SLS's earnings growth rate?
SLS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.
What are SLS's profit margins?
SELLAS Life Sciences Group, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -66.9%.
Is SLS growing earnings?
Yes, SLS earnings are accelerating — EPS growth of +50.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-29M. Earnings momentum is strengthening.
What was SLS's best earnings year?
SELLAS Life Sciences Group, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2006. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.
What were SLS's earnings last quarter?
SLS's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.